🔥🐔 BizChicken 🐔🔥
Companies Similar to Orgenesis Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Mustang Bio, Inc.
Gene and CAR T Cell Therapies
Mustang Bio, Inc. is a biopharmaceutical company specializing in cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. It focuses on developing gene therapy programs and CAR T cell therapies, including treatments for X-linked severe combined immunodeficiency and various types of cancer.
About | Leadership | Directors | News | Contact | About | About | Careers | About | About | Careers | About | About
Symbol: MBIO
Recent Price: $0.19
Industry: Biotechnology
CEO: Dr. Manuel Litchman M.D.
Sector: Healthcare
Employees: 80
Address: 377 Plantation Street, Worcester, MA 01605
Phone: 781 652 4500
Leadership
- Manuel Litchman, M.D., President, Chief Executive Officer and Director
- Greg Furrow, M.S., FRQA, Chief Quality Officer
- James Murphy, B.A., Ad interim Chief Financial Officer
- Michael S. Weiss, Chairman of the Board of Directors
- Lindsay A. Rosenwald, M.D., Director
- Adam J. Chill, Director
- Neil Herskowitz, Director
- Michael J. Zelefsky, M.D., Director
- Mustang Bio, Inc., Company
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Allogene Therapeutics, Inc.
UCART19
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
About | About | About | Contact | Contact | Careers | Careers | Jobs | About | About | About | About | About | About
Symbol: ALLO
Recent Price: $2.10
Industry: Biotechnology
CEO: Dr. David D. Chang M.D., Ph.D.
Sector: Healthcare
Employees: 232
Address: 210 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 457 2700
Last updated: 2024-12-31
AlloVir, Inc.
posoleucel
Allovir, Inc. is a clinical-stage cell therapy company focused on the development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat viral-associated diseases. It was founded in 2013 and is based in Waltham, Massachusetts.
Symbol: ALVR
Recent Price: $0.45
Industry: Biotechnology
CEO: Dr. Diana M. Brainard M.D.
Sector: Healthcare
Employees: 8
Address: 1100 Winter Street, Waltham, MA 02451
Phone: 617 433 2605
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Precision BioSciences, Inc.
ARCUS
Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.
Contact | Careers | Careers | Careers | Careers | Leadership | Leadership | Leadership | Careers | Careers | About | About | About
Symbol: DTIL
Recent Price: $4.26
Industry: Biotechnology
CEO: Mr. Michael Amoroso
Sector: Healthcare
Employees: 109
Address: 302 East Pettigrew Street, Durham, NC 27701
Phone: 919 314 5512
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
NeoGenomics, Inc.
Cancer-focused testing services
Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.
About | About | Leadership | Benefits | About | About | About | About | About | About | Contact | About | About | About
Symbol: NEO
Recent Price: $16.92
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher Michael Smith BSc
Sector: Healthcare
Employees: 2100
Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
Phone: 239 768 0600
Leadership
- Chris Smith, Chief Executive Officer
- Jeff Sherman, Chief Financial Officer
- Warren Stone, Chief Commercial Officer
- Melody Harris, Chief Operations Officer & President, Informatics
- Ali Olivo, Executive Vice President, General Counsel & Business Development
- Hutan Hashemi, JD, Chief Compliance Officer
- Nathan Montgomery, MD, PhD, Vice President, Medical Services
- Gary Passman, Chief Culture Officer
- Kareem Saad, Head of Strategy and Transformation
- Lynn A. Tetrault, Chair of the Board
- Bruce K. Crowther, Board Member
- Elizabeth Floegel, Board Member
- Neil Gunn, Board Member
- Alison L. Hannah, MD, Board Member
- Stephen Kanovsky, Board Member
- Michael A. Kelly, Board Member
- David Perez, Board Member
- Tony Zook, Board Member
- Derek Lyle, MD, Chief Medical Officer
- Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
- J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
- Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
- Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
- Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
- Renuka Agrawal, MD, Senior Hematopathologist
- Todd S. Barry, MD PhD, Senior Hematopathologist
- Bora Baysal, MD, PhD, Senior Hematopathologist
- Saskia Boisot, MD, Senior Hematopathologist
- Wayne W. Chen, MD PhD, Director of Hematopathology Services
- Rachel Flamholz, MD, Senior Hematopathologist
- Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
- Anselm Hii, MD, Director of Hematopathology Services
- Thanh Ho, MD, Senior Hematopathologist
- Kim Janatpour, MD MA, Senior Hematopathologist
- Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
- Sameer S. Khatri, MD, Hematopathologist
- Madeleine Kraus, MD, Senior Hematopathologist
- Brian Kwok, MD FCAP, Corporate Director of Hematopathology
- Keming Lin, MD MS FCAP, Senior Hematopathologist
- Robert Lin, MD, Senior Hematopathologist
- Russell L. Maiese, M.D., Senior Hematopathologist
- Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
- Viera Nelson, MD, Senior Hematopathologist
- Dennis P. O’Malley, MD, Senior Hematopathologist
- Anthony Padula, MD, Senior Hematopathologist
- Munir Shahjahan, MD MPH, Senior Hematopathologist
- Jesalyn J. Taylor, MD, Senior Hematopathologist
- Jian-Feng Wang, MD PhD, Senior Hematopathologist
- Zhao Wu, MD PhD FCAP, Senior Hematopathologist
- Aine Yung, MD FCAP, Senior Hematopathologist
- Sadiq Zaman, MD, Senior Hematopathologist
- Guohua Zhao, MD PhD, Senior Hematopathologist
- Mitual Amin, MD, Senior Surgical Pathologist
- Jerry Chu, MD PhD, Senior Surgical Pathologist
- Ted Farzaneh, MD, Senior Surgical Pathologist
- Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
- Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
- Robert Schwartz, MD, Senior Surgical Pathologist
- Yae K (Kay) Suh, MD, Senior Surgical Pathologist
- Matthew Geller, DO, Molecular Pathologist
- Hao Ho, MD, Molecular Pathologist
- Jennifer Hummel, MD, Senior Molecular Pathologist
- Armen Kaysan, MD, Molecular Pathologist
- Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
- Saed Sadeghi, MD, Molecular Pathologist
- Ying Wang, MD PhD, Molecular Pathologist
- Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
- Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
- Indu Gupta, MD, Surgical Pathologist, Pharma Services
- Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
- Albert Ho, Director of Pharma Pathology Services
- Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
- Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
- Li Cheng, PhD FACMG, Associate Director of Cytogenetics
- Liang Dong, MD PhD, Director of Cytogenetic Services
- Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
- Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
- Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
- John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
- Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
- Farzad Nooraie, MD, Director of Cytogenetic Services
- Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
- Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
- Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
- Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
- Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
- Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
- John N. Allan, MD, Scientific Advisory Board Member
- Rafael Bejar, MD, PhD, Scientific Advisory Board Member
- James R. Berenson, MD, Scientific Advisory Board Member
- Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
- James Downing, MD, Scientific Advisory Board Member
- Bernard A Fox, PhD, Scientific Advisory Board Member
- Gregory Hess, MD, Scientific Advisory Board Member
- Hatim Husain, MD, Scientific Advisory Board Member
- Tibor Kovacsovics, MD, Scientific Advisory Board Member
- Razelle Kurzrock, MD, Scientific Advisory Board Member
- Gail J. Roboz, MD, Scientific Advisory Board Member
- Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
- Mark A. Rubin, MD, Scientific Advisory Board Member
Last updated: 2024-12-31
Ocugen, Inc.
OCU400, OCU410, OCU200
Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies to cure blindness diseases. Its product pipeline includes gene therapy candidates targeting various retinal diseases and other conditions.
Symbol: OCGN
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shankar Musunuri M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 263 Great Valley Parkway, Malvern, PA 19355
Phone: 484 328 4701
Last updated: 2024-12-31
Omega Therapeutics, Inc.
OMEGA Epigenomic Programming platform
Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.
About | Vision/Values | Leadership | Leadership | About | Contact | Contact | About | About
Symbol: OMGA
Recent Price: $0.80
Industry: Biotechnology
CEO: Mr. Mahesh Karande
Sector: Healthcare
Employees: 93
Address: 20 Acorn Park Drive, Cambridge, MA 02140
Phone: 617 949 4360
Leadership
- Mahesh Karande, President & Chief Executive Officer
- Kaan Certel, Ph.D., Chief Business Officer
- Jennifer Nelson, Ph.D., Senior Vice President, Research
- Tony Mullin, Chief People Officer
- Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
- Lisamarie Fahy, Senior Vice President, Clinical Development Operations
- Joe Newman, Ph.D., Senior Vice President, Early Discovery
- Jeff Atkinson, Ph.D., Vice President, Technical Operations
- Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs
Last updated: 2024-12-31
OpGen, Inc.
Acuitas AMR Gene Panel, ARES Technology Platform, Unyvero Platform
Op Gen, Inc. is a precision medicine company focused on developing and commercializing molecular microbiology solutions, including IVD tests for antimicrobial resistance and automated molecular diagnostics platforms.
About | Leadership | Directors | Contact | Contact | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: OPGN
Recent Price: $0.62
Industry: Medical - Diagnostics & Research
CEO: Mr. Honjian Tan
Sector: Healthcare
Employees: 85
Address: 9717 Key West Avenue, Rockville, MD 20850
Phone: 240 813 1260
Leadership
- John Tan Honjian, Chief Executive Officer and Chairman
- David E. Lazar, President
- David Caplon, Corporate Controller
- Christian-Laurent Bonte, Independent Director
- Victor Chua Kok Hoe, Independent Director
- Ken Lim Zhao Qi, Independent Director
- Ethan Low Yu Jie, Director
- Constance Wong Poh Yin, Director
Last updated: 2024-12-31
Organogenesis Holdings Inc.
Advanced Wound Care and Surgical Products
Organogenesis Holdings Inc. develops, manufactures, and commercializes regenerative medicine solutions for advanced wound care, surgical, and sports medicine markets in the United States.
Symbol: ORGO
Recent Price: $3.16
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Gary S. Gillheeney Sr.
Sector: Healthcare
Employees: 862
Address: 85 Dan Road, Canton, MA 02021
Phone: 781 575 0775
Last updated: 2024-12-31
PepGen Inc.
PGN-EDO51
Pep Gen Inc. is a clinical-stage biotechnology company developing oligonucleotide therapeutics for neuromuscular and neurologic diseases. Its lead product, PGN-EDO51, is in Phase I trials for Duchenne muscular dystrophy.
Symbol: PEPG
Recent Price: $3.83
Industry: Biotechnology
CEO: Dr. James G. McArthur Ph.D.
Sector: Healthcare
Employees: 72
Address: 245 Main Street, Cambridge, MA 02142
Phone: 781-797-0979
Last updated: 2024-12-31
Poseida Therapeutics, Inc.
P-PSMA-101
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing innovative CAR-T therapies for patients with high unmet medical needs, including treatments for prostate cancer, multiple myeloma, and various solid tumors.
Symbol: PSTX
Recent Price: $9.48
Industry: Biotechnology
CEO: Dr. Kristin Yarema Ph.D.
Sector: Healthcare
Employees: 337
Address: 9390 Towne Centre Drive, San Diego, CA 92121
Phone: 858 779 3100
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
MeiraGTx Holdings plc
Gene Therapy Treatments
Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.
About | Leadership | About | Contact | About | About | About | News | About | About | About | Directors
Symbol: MGTX
Recent Price: $5.89
Industry: Biotechnology
CEO: Dr. Alexandria Forbes Ph.D.
Sector: Healthcare
Employees: 387
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 860 7985
Leadership
- Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
- Richard Giroux, Chief Operating Officer and Chief Financial Officer
- Stuart Naylor, Ph.D., Chief Development Officer
- Robert K. Zeldin, M.D., Chief Medical Officer
- Robert Wollin, JD, General Counsel and Secretary
- Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
- Christine Sheehy, SVP, Global Integration
- Tim Randall, SVP, Risk and Internal Controls
- Michel Michaelides, M.D., Head of Clinical Ophthalmology
- Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
- Keith R. Harris, Ph.D., Chairman of the Board
- Ellen Hukkelhoven, Ph.D., Board Member
- Lord Mendoza, Independent Board Member
- Nicole Seligman, Independent Board Member
- Thomas E. Shenk, Ph.D., Independent Board Member
- Debra Yu, M.D., Independent Board Member
Last updated: 2024-12-31
Orgenesis Inc.
Point of Care (POCare) platform
Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | News | Careers | Directors | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ORGS
Recent Price: $2.11
Industry: Biotechnology
CEO: Ms. Vered Caplan M.Sc.
Sector: Healthcare
Employees: 146
Address: 20271 Goldenrod Lane, Germantown, MD 20876
Phone: 480 659 6404
Last updated: 2024-12-31